The Division of Microbiology and Infectious Diseases (DMID) within NIAID supports research to better understand, treat, and ultimately prevent infectious diseases caused by virtually all infectious agents, except HIV. The relevant DMID staff contacts for preclinical and clinical services can be found within the following program branches below:
Bacteriology and Mycology Branch
Research portfolios focus on medical mycology, hospital infections (including Acinetobacter, Klebsiella, Serratia, Legionella, Pseudomonas, Aeromonas, Enterobacter, Proteus, non-enteric E. coli, actinomycetes and others), staphylococci, enterococci, bacterial zoonoses (plague, anthrax, tularemia, glanders, melioidosis, Lyme disease, rickettsial diseases, anaplasmosis, ehrlichiosis and Q fever), and leptospirosis.
- Erin Zeituni (preclinical services)
- Erica Raterman (preclinical services)
- Maureen Mehigan (clinical services)
Parasitology and International Programs Branch
Research portfolios focus on protozoan infections, including amebiasis, cryptosporidiosis, cyclosporiasis, giardiasis, leishmaniasis, malaria, trypanosomiasis, toxoplasmosis; helminth infections, including cysticercosis, echinococcosis, lymphatic filariasis, schistosomiasis, onchocerciasis, others (e.g., roundworms, tapeworms, and flukes); invertebrate vectors/ectoparasites, black flies, sandflies, tsetse flies, mosquitoes, ticks, snails, mites; parasite biology (genetics, genomics, physiology, molecular biology, and biochemistry); protective immunity, immunopathogenesis, evasion of host responses; clinical, epidemiologic, and natural history studies of parasitic diseases; research and development of vaccines, drugs, immunotherapeutics, and medical diagnostics, and vector biology and management; mechanisms of pathogen transmission.
- Ghiorghis Ghenbot (preclinical services)
- Greg Deye (clinical services)
- Walt Jones (clinical services)
Respiratory Diseases Branch
Research portfolios focus on viral respiratory diseases caused by influenza viruses, human coronaviruses including SARS, MERS, and novel emerging coronaviruses, rhinoviruses, respiratory syncytial virus and other related paramyxoviruses; mycobacterial diseases, including tuberculosis, leprosy, Buruli ulcer and non-tuberculous mycobacterial diseases (particularly those causing lung infections in persons who are not also afflicted with HIV/AIDS); other bacterial respiratory diseases including acute otitis media, pharyngitis, community acquired pneumonia, acute exacerbations of chronic obstructive pulmonary disease, diphtheria, pertussis, acute rhinosinusitis, streptococcal disease; and mixed viral/bacterial respiratory infections.
- André McBride (preclinical services: tuberculosis, leprosy, non-tuberculous mycobacteria)
- Chelsea Lane (preclinical services: respiratory viruses, respiratory bacteria)
- Chris Roberts (clinical services)
Enteric and Sexually Transmitted Infections Branch
The Enteric and Sexually Transmitted Infections Branch is interested in microbes that infect and colonize the genitourinary and gastrointestinal tracts.
The Sexually Transmitted Infections (STI) research portfolios focus on gonorrhea, chlamydia, syphilis, chancroid, sexually transmitted mycoplasma infections, infections caused by Ureplasma urealyticum and Mycoplasma genitalium, bacterial vaginosis, genital herpes or HSV-2, genital warts, HPV, trichomoniasis, other sexually transmitted infections (excluding hepatitis B and HIV), conditions arising from sexually transmitted infections (e.g. pelvic inflammatory disease, infertility, chronic pelvic pain, ectopic pregnancy, adverse outcomes of pregnancy, pre-term delivery, and congenital or neonatal infections), and the development of topical microbicides and multi-purpose prevention technologies.
The Enteric research portfolios focus on enteric bacterial infections caused by Aeromonas spp., Campylobacter spp., Clostridioides spp., Clostridium spp., diarrheagenic Escherichia coli, Helicobacter spp., Listeria spp., Salmonella spp., Shigella spp., Vibrio spp., enteric Yersinia spp., and the gut microbiome, as well as Bacteroides enterotoxins, botulinum toxin, ricin toxin, Shiga and Shiga-like toxins, and Staphylococcus Enterotoxin B (SEB).
- Kimberly Murphy (STI preclinical services)
- Christian Gonzalez (Enteric preclinical services)
- Carolyn Deal (clinical services)
Research portfolios focus on acute viral infections (including Nipah and Hendra viruses), arthropod-borne and rodent-borne viral diseases (including Dengue, Zika, West Nile, Japanese encephalitis, Chikungunya, yellow fever, hantavirus, etc.), viral hemorrhagic fevers (Ebola, Lassa fever, etc.), measles, polio, coxsackie virus, enteroviruses, poxviruses, rabies, rubella, and persistent viral diseases (including adenoviruses, BK virus, bornaviruses, coronaviruses, herpesviruses, human T-lymphotrophic virus, JC virus, human papillomaviruses, parvoviruses, emerging human polyomaviruses, and prion diseases).
- Liane Agulto (preclinical services)
- Walla Dempsey (clinical services)
Office of Biodefense, Research Resources and Translational Research
The Office of Biodefense, Research Resources and Translational Research (OBRRTR) supports biodefense and emerging infectious disease countermeasure development through contracts, supports translational research centers and partnerships, and provides preclinical development services, from reagents, assays and animal models to product-specific services for vaccines, therapeutics and diagnostics.
- Kim Taylor (vaccine services)
- Rick Sciotti (therapeutic services)
- Mark Williams (research resources)
- Michael Schaefer (translational research)